Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Camille Lemieux"'
Autor:
Gaston De Serres, Danuta M Skowronski, Brian J Ward, Michael Gardam, Camille Lemieux, Annalee Yassi, David M Patrick, Mel Krajden, Mark Loeb, Peter Collignon, Fabrice Carrat
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0163586 (2017)
BACKGROUND:Four cluster randomized controlled trials (cRCTs) conducted in long-term care facilities (LTCFs) have reported reductions in patient risk through increased healthcare worker (HCW) influenza vaccination. This evidence has led to expansive p
Externí odkaz:
https://doaj.org/article/05679d7a28ff499ba88ef07658dffc00
Publikováno v:
Emerging Infectious Diseases, Vol 13, Iss 1, Pp 173-173 (2007)
Externí odkaz:
https://doaj.org/article/edeb616783f14ea0b21671890e2f7105
Autor:
Warren J. McIsaac, Andrew Morris, Yoshiko Nakamachi, David Tannenbaum, Michelle Levy, Camille Lemieux, Rahim Moineddin, Linda Dresser, Sakina Walji, Jeff Bloom, Sahana Kukan, Patricia Marr, Suzanne Singh, Nelia De Oliveira, Mark McIntyre, Arrani Senthinathan, Mira Mitri
Publikováno v:
J Assoc Med Microbiol Infect Dis Can
Effective community-based antimicrobial stewardship programs (ASPs) are needed because 90% of antimicrobials are prescribed in the community. A primary care ASP (PC-ASP) was evaluated for its effectiveness in lowering antibiotic prescriptions for six
Autor:
Yoshiko Nakamachi, Shiran Isaacksz, Andrew P. Costa, Aaron Jones, Lauren Lapointe-Shaw, Allison McGeer, Paula A. Rochon, Arjumand Siddiqi, Camille Lemieux, Kevin A. Brown, Christa Sinclair Mills, Nathan M. Stall, Tai Huynh, Brian Hodges, Antonina Maltsev, Elizabeth Niedra, Samir K. Sinha, Peter Juni, Sophia Ikura, Melissa Chang, Adam Thurston
Homebound individuals face substantial barriers to receiving COVID-19 vaccines as they cannot or rarely leave their homes because of medical, psychiatric, cognitive, functional, transportation-related and social reasons. There are at least 75,000 Ont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4070b598ee2edbc1940991dab3a55ad1
https://doi.org/10.47326/ocsat.2021.02.19.1.0
https://doi.org/10.47326/ocsat.2021.02.19.1.0
Autor:
Joshua Booth, Deepali Kumar, Sergio Borgia, Colin Hislop, Seham Noureldin, Camille Lemieux, Ingrid Choong, Rachel Hong, Jeffrey S. Glenn, Jordan J. Feld, Tiffany Chan, Braden O’Neil, Julia Casey, Bryan Coburn, Anjali Patel, Atul Humar, Wesam Aleyadeh, Andrea K. Boggild, Darrell H. S. Tan, Christopher Kandel, David Smookler, Adam J. Gehring, Harry L.A. Janssen, D. L. Tyrrell, Bettina E. Hansen, Ryan Hiebert, Janine McCready, Deanna M. Santer, Jeff Powis, Robert A. Kozak, Bethany Barber, Mia J. Biondi, Zahoor Ma, Adrienne K. Chan, Henna Mistry
SummaryBackgroundThere are currently no effective treatments for outpatients with coronavirus disease 2019 (COVID-19). Interferon-lambda-1 is a Type III interferon involved in the innate antiviral response with activity against respiratory pathogens.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a859470e85b7488ac314f6351bc7287f
https://doi.org/10.1101/2020.11.09.20228098
https://doi.org/10.1101/2020.11.09.20228098
Autor:
Seham Noureldin, David Smookler, Adam J. Gehring, Sergio Borgia, Andrea K. Boggild, Bryan Coburn, Ryan Hiebert, Janine McCready, Tiffany Chan, Muhammad Atif Zahoor, Atul Humar, Wesam Aleyadeh, Jeffrey S. Glenn, Christopher Kandel, Adrienne K. Chan, Julia Casey, Robert A. Kozak, Camille Lemieux, Bethany Barber, Henna Mistry, Ingrid Choong, Darrell H. S. Tan, D. Lorne Tyrrell, Colin Hislop, Rachel Hong, Jordan J. Feld, Deepali Kumar, Braden O’Neil, Anjali Patel, Harry L.A. Janssen, Bettina E. Hansen, Mia J. Biondi, Deanna M. Santer, Jeff Powis, Joshua Booth
Publikováno v:
The Lancet. Respiratory Medicine
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine
Summary Background To date, only monoclonal antibodies have been shown to be effective for outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate antiviral responses with activity against respiratory pathogens. We
Autor:
Camille Lemieux, Bettina E. Hansen, Lorne Tyrrell, Deepali Kumar, Ingrid Choong, Rachel Hong, Jeffrey S. Glenn, Seham Noureldin, Sergio Borgia, Andrea K. Boggild, Darrell H. S. Tan, Robert A. Kozak, Harry L.A. Janssen, Tiffany Chan, Adrienne K. Chan, Christopher Kandel, Julia Casey, Janine McCready, Henna Mistry, Atif Zahoor, Jordan J. Feld, Braden O’Neil, Anjali Patel, Bethany Barber, David Smookler, Adam J. Gehring, Mia J. Biondi, Deanna M. Santer, Joshua Booth, Jeff Powis, Atul Humar, Colin Hislop, Bryan Coburn, Ryan Hiebert, Wesam Aleyadeh
Publikováno v:
SSRN Electronic Journal.
Background: There are currently no effective treatments for outpatients with coronavirus disease. 2019 (COVID-19). Interferon-lambda-1 is a Type III interferon involved in the innate antiviral response with activity against respiratory pathogens. Met
Autor:
Kevin C. Katz, George R. Golding, Kelly Baekyung Choi, Linda Pelude, Kanchana R. Amaratunga, Monica Taljaard, Stephanie Alexandre, Jun Chen Collet, Ian Davis, Tim Du, Gerald A. Evans, Charles Frenette, Denise Gravel, Susy Hota, Pamela Kibsey, Joanne M. Langley, Bonita E. Lee, Camille Lemieux, Yves Longtin, Dominik Mertz, Lorraine Maze Dit Mieusement, Jessica Minion, Dorothy L. Moore, Michael R. Mulvey, Susan Richardson, Michelle Science, Andrew E. Simor, Paula Stagg, Kathryn N. Suh, Geoffrey Taylor, Alice Wong, Nisha Thampi
Publikováno v:
Canadian Medical Association Journal. 190:E758-E765
Background: The clinical and molecular epidemiology of health care–associated Clostridium difficile infection in nonepidemic settings across Canada has evolved since the first report of the virulent North American pulsed-field gel electrophoresis t
Autor:
Dominik Mertz, Camille Lemieux, Kanchana Amaratunga, Stephanie Smith, Lynn Johnston, Michael John, Elizabeth Henderson, Ian Davis, Robyn Mitchell, Virginia Roth, Linda Pelude, Denise Gravel, Julie Vachon, Stephanie Alexandre, Mary Vearncombe
Publikováno v:
Infection Control & Hospital Epidemiology. 38:147-153
BACKGROUNDHip and knee arthroplasty infections are associated with considerable healthcare costs. The merits of reducing the postoperative surveillance period from 1 year to 90 days have been debated.OBJECTIVESTo report the first pan-Canadian hip and
Autor:
Gerald A Evans, Michael Gardam, Camille Lemieux, Susy Hota, Cameron Coulby, Kathryn N. Suh, Carl vanWalraven, Virginia Roth, Michael John, Elisa Vicencio
Publikováno v:
Infection Control & Hospital Epidemiology. 38:24-30
OBJECTIVETo assess clinically relevant outcomes after complete cessation of control measures for vancomycin-resistant enterococci (VRE).DESIGNQuasi-experimental ecological study over 3.5 years.METHODSAll VRE screening and isolation practices at 4 lar